| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | agenesis of the corpus callosum with peripheral neuropathy | SLC12A6* | Slc12a6* | 3 models | Alliance of Genome Resources | ||
| Alzheimer's disease | PSEN1* | Psen1* | 19 models | Alliance of Genome Resources | |||
| Alzheimer's disease | PLAU* | Plau* | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | MME* | Mme* | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | LRP1* | Lrp1* | 2 models | Alliance of Genome Resources | |||
| Alzheimer's disease | APP* | App* | 24 models | Alliance of Genome Resources | |||
| Alzheimer's disease 3 | PSEN1* | Psen1* | 6 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | SOD1* | Sod1* | 2 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 10 | TARDBP* | Tardbp* | 7 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 21 | MATR3* | Matr3* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 4 | SETX* | Setx* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 6 | FUS* | Fus* | 1 model | Alliance of Genome Resources | |||
| ataxia telangiectasia | ATM* | Atm* | 9 models | Alliance of Genome Resources | |||
| autosomal dominant distal hereditary motor neuronopathy 2 | HSPB8* | Hspb8* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive distal hereditary motor neuronopathy 1 | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 12 | WWOX* | Wwox* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 13 | GRM1* | Grm1* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 16 | STUB1* | Stub1* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive spinocerebellar ataxia 18 | GRID2* | Grid2* | 2 models | Alliance of Genome Resources | |||
| Cayman type cerebellar ataxia | ATCAY* | Atcay* | 3 models | Alliance of Genome Resources | |||
| cerebellar ataxia type 42 | CACNA1G* | Cacna1g* | 2 models | Alliance of Genome Resources | |||
| Charlevoix-Saguenay spastic ataxia | SACS* | Sacs* | 2 models | Alliance of Genome Resources | |||
| choreaacanthocytosis | VPS13A* | Vps13a* | 1 model | Alliance of Genome Resources | |||
| episodic ataxia type 1 | KCNA1* | Kcna1* | 1 model | Alliance of Genome Resources | |||
| episodic ataxia type 2 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
| familial encephalopathy with neuroserpin inclusion bodies | SERPINI1* | Serpini1* | 1 model | Alliance of Genome Resources | |||
| fragile X-associated tremor/ataxia syndrome | FMR1* | Fmr1* | 1 model | Alliance of Genome Resources | |||
| Friedreich ataxia | FXN* | Fxn* | 8 models | Alliance of Genome Resources | |||
| Huntington's disease | HTT* | Htt* | 21 models | Alliance of Genome Resources | |||
| juvenile spinal muscular atrophy | SMN1*, SMN2* | Smn1* | 2 models | Alliance of Genome Resources | |||
| Kufor-Rakeb syndrome | ATP13A2* | Atp13a2* | 1 model | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 2a | PLA2G6* | Pla2g6* | 4 models | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 5 | WDR45* | Wdr45* | 2 models | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 6 | COASY* | Coasy* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | VPS35* | Vps35* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | TFAM* | Tfam* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | PPARGC1A* | Ppargc1a* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | NR4A2* | Nr4a2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | EN1* | En1* | 3 models | Alliance of Genome Resources | |||
| Parkinson's disease 1 | SNCA* | Snca* | 6 models | Alliance of Genome Resources | |||
| Parkinson's disease 14 | PLA2G6* | Pla2g6* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease 17 | VPS35* | Vps35* | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease 2 | PRKN* | Prkn* | 9 models | Alliance of Genome Resources | |||
| Parkinson's disease 4 | SNCA* | Snca* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease 6 | PINK1* | Pink1* | 4 models | Alliance of Genome Resources | |||
| Parkinson's disease 7 | PARK7* | Park7* | 4 models | Alliance of Genome Resources | |||
| Parkinson's disease 8 | LRRK2* | Lrrk2* | 1 model | Alliance of Genome Resources | |||
| pontocerebellar hypoplasia type 10 | CLP1* | Clp1* | 3 models | Alliance of Genome Resources | |||
| pontocerebellar hypoplasia type 14 | PPIL1* | Ppil1* | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 1 | ATXN1* | Atxn1* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 14 | PRKCG* | Prkcg* | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 17 | TBP* | Tbp* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 2 | ATXN2* | Atxn2* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 28 | AFG3L2* | Afg3l2* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 5 | SPTBN2* | Sptbn2* | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 6 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 7 | ATXN7* | Atxn7* | 5 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia with axonal neuropathy 1 | TDP1* | Tdp1* | 1 model | Alliance of Genome Resources | |||
| Werdnig-Hoffmann disease | SMN1*, SMN2 | Smn1* | 17 models | Alliance of Genome Resources | |||
| X-linked distal spinal muscular atrophy 3 | ATP7A* | Atp7a* | 2 models | Alliance of Genome Resources | |||
| | Alzheimer's disease | PLCB1 | Plcb1* | 1 model | Alliance of Genome Resources | ||
| Alzheimer's disease | PIN1 | Pin1*, Pin1rt1 | 2 models | Alliance of Genome Resources | |||
| Alzheimer's disease | IL33 | Il33* | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | CAV1 | Cav1* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | ZNF106 | Zfp106* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | STMN2 | Stmn2* | 2 models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | PSMC4 | Psmc4* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | EPG5 | Epg5* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis | ADARB1 | Adarb1* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | SNCG | Sncg* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | VEGFA | Vegfa* | 1 model | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 1 | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
| cerebellar ataxia | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
| Charlevoix-Saguenay spastic ataxia | ANKFY1 | Ankfy1* | 1 model | Alliance of Genome Resources | |||
| hereditary ataxia | SCYL1 | Scyl1* | 1 model | Alliance of Genome Resources | |||
| hereditary ataxia | RNF170 | Rnf170* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | PPARD | Ppard* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | ZDHHC13 | Zdhhc13* | 1 model | Alliance of Genome Resources | |||
| Huntington's disease | ZDHHC17 | Zdhhc17* | 1 model | Alliance of Genome Resources | |||
| motor neuron disease | RHOT1 | Rhot1* | 1 model | Alliance of Genome Resources | |||
| neurodegeneration with brain iron accumulation 2a | gnd* | 1 model | |||||
| neurodegeneration with brain iron accumulation 2a | inad* | 1 model | |||||
| neurodegeneration with brain iron accumulation 2a | nad* | 1 model | |||||
| neurodegenerative disease | CLEC16A | Clec16a* | 1 model | Alliance of Genome Resources | |||
| neurodegenerative disease | HPDL | Hpdl* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | KCNN2 | Kcnn2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | TWNK | Twnk* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | SPR | Spr* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | RRN3, RRN3P1, RRN3P2 | Rrn3* | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease | PITX3 | Pitx3* | 3 models | Alliance of Genome Resources | |||
| Parkinson's disease | nm3* | 1 model | |||||
| Parkinson's disease | ADCY5 | Adcy5* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | ADH7 | Adh7* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | ATG7 | Atg7* | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease | COX10 | Cox10* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | DRD2 | Drd2* | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | MINAR2 | Minar2* | 1 model | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 27 | FGF14 | Fgf14* | 1 model | Alliance of Genome Resources | |||
| Werdnig-Hoffmann disease | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
| | adult spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | |||
| Alzheimer's disease | NTF3* | Ntf3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | LIPC* | Lipc | Alliance of Genome Resources | ||||
| Alzheimer's disease | LPL* | Lpl | Alliance of Genome Resources | ||||
| Alzheimer's disease | LRP8* | Lrp8 | Alliance of Genome Resources | ||||
| Alzheimer's disease | LRPAP1* | Lrpap1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MAOA* | Maoa | Alliance of Genome Resources | ||||
| Alzheimer's disease | MAOB* | Maob | Alliance of Genome Resources | ||||
| Alzheimer's disease | MAPT* | Mapt | 2 models | Alliance of Genome Resources | |||
| Alzheimer's disease | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MCM2* | Mcm2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | MT3* | Mt3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NCF2* | Ncf2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NCSTN* | Ncstn | Alliance of Genome Resources | ||||
| Alzheimer's disease | NECTIN2* | Nectin2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NEFM* | Nefm | Alliance of Genome Resources | ||||
| Alzheimer's disease | NFE2L2* | Nfe2l2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NGFR* | Ngfr | Alliance of Genome Resources | ||||
| Alzheimer's disease | NOS1* | Nos1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NTRK1* | Ntrk1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PARP1* | Parp1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PCK1* | Pck1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PNMT* | Pnmt | Alliance of Genome Resources | ||||
| Alzheimer's disease | PON1* | Pon1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PON2* | Pon2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PON3* | Pon3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPARA* | Ppara | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPARG* | Pparg | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
| Alzheimer's disease | PPP3R1* | Ppp3r1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | PSEN2* | Psen2 | 3 models | Alliance of Genome Resources | |||
| Alzheimer's disease | RCAN1* | Rcan1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | S100B* | S100b | Alliance of Genome Resources | ||||
| Alzheimer's disease | SERPINE2* | Serpine2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | SNCA* | Snca | Alliance of Genome Resources | ||||
| Alzheimer's disease | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | SORL1* | Sorl1 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TFAM* | Tfam | Alliance of Genome Resources | ||||
| Alzheimer's disease | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TNF* | Tnf | Alliance of Genome Resources | ||||
| Alzheimer's disease | TPH1* | Tph1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | TTR* | Ttr | Alliance of Genome Resources | ||||
| Alzheimer's disease | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | UQCRC1* | Uqcrc1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| Alzheimer's disease | VLDLR* | Vldlr | Alliance of Genome Resources | ||||
| Alzheimer's disease | WT1* | Wt1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | XRN1* | Xrn1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | A2M* | A2m | Alliance of Genome Resources | ||||
| Alzheimer's disease | ABAT* | Abat | Alliance of Genome Resources | ||||
| Alzheimer's disease | ABCA1* | Abca1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ACHE* | Ache | Alliance of Genome Resources | ||||
| Alzheimer's disease | ADAM17* | Adam17 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ADRA1A* | Adra1a | Alliance of Genome Resources | ||||
| Alzheimer's disease | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | AGER* | Ager | Alliance of Genome Resources | ||||
| Alzheimer's disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | ALDH2* | Aldh2 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | APBB1* | Apbb1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APBB2* | Apbb2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOA1* | Apoa1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOA4* | Apoa4 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | APOC1* | Apoc1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | APOE* | Apoe | 4 models | Alliance of Genome Resources | |||
| Alzheimer's disease | BACE1* | Bace1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | BACE2* | Bace2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | BCHE* | Bche | Alliance of Genome Resources | ||||
| Alzheimer's disease | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Alzheimer's disease | C2* | C2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | C3* | C3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CASP7* | Casp7 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CDK5* | Cdk5 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CDK5R1* | Cdk5r1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CHAT* | Chat | Alliance of Genome Resources | ||||
| Alzheimer's disease | CLOCK* | Clock | Alliance of Genome Resources | ||||
| Alzheimer's disease | CTSD* | Ctsd | Alliance of Genome Resources | ||||
| Alzheimer's disease | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | CYP46A1* | Cyp46a1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | DLST* | Dlst | Alliance of Genome Resources | ||||
| Alzheimer's disease | ECE1* | Ece1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | EIF2S1* | Eif2s1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ENO1* | Eno1, Eno1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | EPO* | Epo | Alliance of Genome Resources | ||||
| Alzheimer's disease | ESR1* | Esr1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | FAS* | Fas | Alliance of Genome Resources | ||||
| Alzheimer's disease | FYN* | Fyn | Alliance of Genome Resources | ||||
| Alzheimer's disease | GAPDH* | Gapdh, Gapdh-ps15, Gapdhrt, Gapdhrt2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GAPDHS* | Gapdhs | Alliance of Genome Resources | ||||
| Alzheimer's disease | GCG* | Gcg | Alliance of Genome Resources | ||||
| Alzheimer's disease | GLUL* | Glul | Alliance of Genome Resources | ||||
| Alzheimer's disease | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
| Alzheimer's disease | GRN* | Grn | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSK3B* | Gsk3b | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSS* | Gss | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTO1* | Gsto1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTO2* | Gsto2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| Alzheimer's disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | HFE* | Hfe | Alliance of Genome Resources | ||||
| Alzheimer's disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
| Alzheimer's disease | HSPA1A*, HSPA1B* | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | HTR6* | Htr6 | Alliance of Genome Resources | ||||
| Alzheimer's disease | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL1A* | Il1a | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL2* | Il2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL4* | Il4 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL6R* | Il6ra | Alliance of Genome Resources | ||||
| Alzheimer's disease | IL10* | Il10 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IREB2* | Ireb2 | Alliance of Genome Resources | ||||
| Alzheimer's disease | IRS1* | Irs1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
| Alzheimer's disease | KLC1* | Klc1 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| Alzheimer's disease | LDLR* | Ldlr | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease 1 | PLAU* | Plau | Alliance of Genome Resources | ||||
| Alzheimer's disease 1 | APP* | App | Alliance of Genome Resources | ||||
| Alzheimer's disease 1 | MPO* | Mpo | Alliance of Genome Resources | ||||
| Alzheimer's disease 18 | ADAM10* | Adam10 | Alliance of Genome Resources | ||||
| Alzheimer's disease 2 | APOE* | Apoe | Alliance of Genome Resources | ||||
| Alzheimer's disease 3 | APOE* | Apoe | Alliance of Genome Resources | ||||
| Alzheimer's disease 4 | PSEN2* | Psen2 | 1 model | Alliance of Genome Resources | |||
| Alzheimer's disease 9 | ABCA7* | Abca7 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | SLC11A2* | Slc11a2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | PON3* | Pon3 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | PON2* | Pon2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | OPTN* | Optn | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | NEFL* | Nefl | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | ALS2* | Als2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | ITPR2* | Itpr2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | HMGB1* | Hmgb1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GSK3B* | Gsk3b | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GSK3A* | Gsk3a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GRN* | Grn | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | GOT1* | Got1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | FUS* | Fus | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | APOE* | Apoe | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | CHMP2B* | Chmp2b | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | CCS* | Ccs | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | NEFH* | Nefh | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | AOX1* | Aox1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | VAPB* | Vapb | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | UNC13A* | Unc13a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | UBQLN2* | Ubqln2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | TXNRD1* | Txnrd1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | TFAM* | Tfam | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 | TRPM7* | Trpm7 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 1 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 1 | NEFH* | Nefh | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 1 | PRPH* | Prph | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 11 | FIG4* | Fig4 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 12 | OPTN* | Optn | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 15 | UBQLN2* | Ubqln2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 16 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 18 | PFN1* | Pfn1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 19 | ERBB4* | Erbb4 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 2 | ALS2* | Als2 | 3 "NOT" models | Alliance of Genome Resources | |||
| amyotrophic lateral sclerosis type 20 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 22 | TUBA4A* | Tuba4a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 23 | ANXA11* | Anxa11 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 24 | NEK1* | Nek1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 25 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 26 | TIA1* | Tia1 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 28 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 5 | SPG11* | Spg11 | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 8 | VAPB* | Vapb | Alliance of Genome Resources | ||||
| amyotrophic lateral sclerosis type 9 | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| ataxia-oculomotor apraxia type 4 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
| ataxia telangiectasia | BIK* | Bik | Alliance of Genome Resources | ||||
| ataxia telangiectasia | IFNG* | Ifng | Alliance of Genome Resources | ||||
| ataxia telangiectasia | IL2* | Il2 | Alliance of Genome Resources | ||||
| ataxia telangiectasia | BAK1* | Bak1 | Alliance of Genome Resources | ||||
| ataxia telangiectasia | BAX* | Bax | Alliance of Genome Resources | ||||
| ataxia telangiectasia | HDAC4* | Hdac4 | Alliance of Genome Resources | ||||
| ataxia-telangiectasia-like disorder-1 | MRE11* | Mre11a | Alliance of Genome Resources | ||||
| ataxia-telangiectasia-like disorder-2 | PCNA* | Pcna | Alliance of Genome Resources | ||||
| ataxia with oculomotor apraxia type 1 | APTX* | Aptx | Alliance of Genome Resources | ||||
| ataxia with oculomotor apraxia type 3 | PIK3R5* | Pik3r5 | Alliance of Genome Resources | ||||
| autosomal dominant adult-onset proximal spinal muscular atrophy | VAPB* | Vapb | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia | NPTX1* | Nptx1 | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia | SAMD9L* | Samd9l | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia | FGF14* | Fgf14 | Alliance of Genome Resources | ||||
| autosomal dominant cerebellar ataxia, deafness and narcolepsy | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 10 | EMILIN1* | Emilin1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 11 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 12 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 13 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 14 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 3 | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 4 | HSPB3* | Hspb3 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 5 | GARS1* | Gars1 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 6 | FBXO38* | Fbxo38 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 7 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 8 | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
| autosomal dominant distal hereditary motor neuronopathy 9 | WARS1* | Wars1 | Alliance of Genome Resources | ||||
| autosomal dominant sensory ataxia 1 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 10 | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 2 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 4 | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 5 | DNAJB2* | Dnajb2 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 6 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 7 | VWA1* | Vwa1 | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 8 | SORD* | Sord | Alliance of Genome Resources | ||||
| autosomal recessive distal hereditary motor neuronopathy 9 | COQ7* | Coq7 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 10 | ANO10* | Ano10 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 11 | SYT14* | Syt14 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 14 | SPTBN2* | Sptbn2 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 15 | RUBCN* | Rubcn | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 17 | CWF19L1* | Cwf19l1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 19 | SLC9A1* | Slc9a1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 2 | PMPCA* | Pmpca | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 20 | SNX14* | Snx14 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 21 | SCYL1* | Scyl1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 22 | VWA3B* | Vwa3b | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 23 | TDP2* | Tdp2 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 24 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 25 | ATG5* | Atg5 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 26 | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 27 | GDAP2* | Gdap2 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 28 | THG1L* | Thg1l | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 29 | VPS41* | Vps41 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 30 | PITRM1* | Pitrm1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 31 | ATG7* | Atg7 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 32 | PRDX3* | Prdx3 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 33 | RNU12* | ||||||
| autosomal recessive spinocerebellar ataxia 4 | VPS13D* | Vps13d | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 7 | TPP1* | Tpp1 | Alliance of Genome Resources | ||||
| autosomal recessive spinocerebellar ataxia 8 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
| cerebellar ataxia | POLG* | Polg | Alliance of Genome Resources | ||||
| cerebellar ataxia | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
| cerebellar ataxia | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
| cerebellar ataxia | ATCAY* | Atcay | Alliance of Genome Resources | ||||
| cerebellar ataxia | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
| cerebellar ataxia type 41 | TRPC3* | Trpc3 | Alliance of Genome Resources | ||||
| cerebellar ataxia type 43 | MME* | Mme | Alliance of Genome Resources | ||||
| cerebellar ataxia type 47 | PUM1* | Pum1 | Alliance of Genome Resources | ||||
| cerebellar ataxia type 48 | STUB1* | Stub1 | Alliance of Genome Resources | ||||
| childhood-onset neurodegeneration with brain atrophy | UBTF* | Ubtf | Alliance of Genome Resources | ||||
| dentatorubral-pallidoluysian atrophy | ATN1* | Atn1 | Alliance of Genome Resources | ||||
| episodic ataxia | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
| episodic ataxia type 5 | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
| episodic ataxia type 6 | SLC1A3* | Slc1a3 | Alliance of Genome Resources | ||||
| episodic ataxia type 9 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
| familial encephalopathy with neuroserpin inclusion bodies | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
| Fazio-Londe disease | SLC52A3* | Slc52a3 | Alliance of Genome Resources | ||||
| Friedreich ataxia | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
| Friedreich ataxia | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| Friedreich ataxia 1 | FXN* | Fxn | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | C9orf72* | C9orf72 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | TBK1* | Tbk1 | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | VCP* | Vcp | Alliance of Genome Resources | ||||
| frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | CHMP2B* | Chmp2b | Alliance of Genome Resources | ||||
| Huntington's disease | ABAT* | Abat | Alliance of Genome Resources | ||||
| Huntington's disease | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Huntington's disease | CNTF* | Cntf | Alliance of Genome Resources | ||||
| Huntington's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| Huntington's disease | GLUL* | Glul | Alliance of Genome Resources | ||||
| Huntington's disease | GRIK2* | Grik2 | Alliance of Genome Resources | ||||
| Huntington's disease | GRIN2A* | Grin2a | Alliance of Genome Resources | ||||
| Huntington's disease | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
| Huntington's disease | HAP1* | Hap1 | 2 "NOT" models | Alliance of Genome Resources | |||
| Huntington's disease | HSF1* | Hsf1 | Alliance of Genome Resources | ||||
| Huntington's disease | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| Huntington's disease | IL6* | Il6 | Alliance of Genome Resources | ||||
| Huntington's disease | IL6R* | Il6ra | Alliance of Genome Resources | ||||
| Huntington's disease | MAP3K5* | Map3k5 | Alliance of Genome Resources | ||||
| Huntington's disease | NOG* | Nog | Alliance of Genome Resources | ||||
| Huntington's disease | NPY* | Npy | Alliance of Genome Resources | ||||
| Huntington's disease | NPY2R* | Npy2r | Alliance of Genome Resources | ||||
| Huntington's disease | NRF1* | Nrf1 | Alliance of Genome Resources | ||||
| Huntington's disease | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
| Huntington's disease | PRKAA1* | Prkaa1 | Alliance of Genome Resources | ||||
| Huntington's disease | SIRT1* | Sirt1 | Alliance of Genome Resources | ||||
| Huntington's disease | TFAM* | Tfam | Alliance of Genome Resources | ||||
| Huntington's disease-like 2 | JPH3* | Jph3 | Alliance of Genome Resources | ||||
| infantile cerebellar-retinal degeneration | ACO2* | Aco2 | Alliance of Genome Resources | ||||
| intermediate spinal muscular atrophy | SMN1*, SMN2 | Smn1 | 1 model | Alliance of Genome Resources | |||
| juvenile amyotrophic lateral sclerosis type 27 | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
| Kennedy's disease | AR* | Ar | 1 model | Alliance of Genome Resources | |||
| late onset Parkinson's disease | EIF4G1* | Eif4g1 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ATXN3* | Atxn3 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | GBA1* | Gba1 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | TBP* | Tbp | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ADH1C*, ADH1A, ADH1B | Adh1 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ATXN2* | Atxn2 | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | ATXN8OS* | ||||||
| late onset Parkinson's disease | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
| late onset Parkinson's disease | PSAP* | Psap | Alliance of Genome Resources | ||||
| Machado-Joseph disease | ATXN3* | Atxn3 | 1 model | Alliance of Genome Resources | |||
| Machado-Joseph disease | BECN1* | Becn1 | Alliance of Genome Resources | ||||
| McLeod syndrome | XK* | Xk | Alliance of Genome Resources | ||||
| motor neuron disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| motor neuron disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| motor neuron disease | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
| motor neuron disease | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
| multiple system atrophy | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation | CRAT* | Crat | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation | REPS1* | Reps1 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation | FTH1* | Fth1 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation 2b | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation 3 | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
| neurodegeneration with brain iron accumulation 4 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
| neurodegenerative disease | EPO* | Epo | Alliance of Genome Resources | ||||
| neurodegenerative disease | FUS* | Fus | Alliance of Genome Resources | ||||
| neurodegenerative disease | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
| neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | IRF2BPL* | Irf2bpl | Alliance of Genome Resources | ||||
| neuronal intranuclear inclusion disease | NOTCH2NLC* | ||||||
| nonprogressive cerebellar ataxia with mental retardation | CAMTA1* | Camta1 | Alliance of Genome Resources | ||||
| olivopontocerebellar atrophy | APTX* | Aptx | Alliance of Genome Resources | ||||
| pantothenate kinase-associated neurodegeneration | PANK2* | Pank2 | 1 "NOT" model | Alliance of Genome Resources | |||
| Parkinson's disease | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| Parkinson's disease | NDUFV2* | Ndufv2 | Alliance of Genome Resources | ||||
| Parkinson's disease | NOS1* | Nos1 | Alliance of Genome Resources | ||||
| Parkinson's disease | NQO2* | Nqo2 | Alliance of Genome Resources | ||||
| Parkinson's disease | PARK7* | Park7 | Alliance of Genome Resources | ||||
| Parkinson's disease | PARP1* | Parp1 | Alliance of Genome Resources | ||||
| Parkinson's disease | PHACTR2* | Phactr2 | Alliance of Genome Resources | ||||
| Parkinson's disease | PINK1* | Pink1 | 2 models | Alliance of Genome Resources | |||
| Parkinson's disease | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| Parkinson's disease | POLG* | Polg | Alliance of Genome Resources | ||||
| Parkinson's disease | PRKN* | Prkn | Alliance of Genome Resources | ||||
| Parkinson's disease | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
| Parkinson's disease | S100B* | S100b | Alliance of Genome Resources | ||||
| Parkinson's disease | SEPTIN14* | Septin14 | Alliance of Genome Resources | ||||
| Parkinson's disease | SLC11A2* | Slc11a2 | Alliance of Genome Resources | ||||
| Parkinson's disease | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
| Parkinson's disease | SNCA* | Snca | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | VDR* | Vdr | Alliance of Genome Resources | ||||
| Parkinson's disease | UCHL1* | Uchl1 | 1 model | Alliance of Genome Resources | |||
| Parkinson's disease | TH* | Th | Alliance of Genome Resources | ||||
| Parkinson's disease | TCN2* | Tcn2 | Alliance of Genome Resources | ||||
| Parkinson's disease | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
| Parkinson's disease | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
| Parkinson's disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| Parkinson's disease | SNCB* | Sncb | Alliance of Genome Resources | ||||
| Parkinson's disease | HNMT* | Hnmt | Alliance of Genome Resources | ||||
| Parkinson's disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
| Parkinson's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Parkinson's disease | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTO2* | Gsto2 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTO1* | Gsto1 | Alliance of Genome Resources | ||||
| Parkinson's disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| Parkinson's disease | GRK6* | Grk6 | Alliance of Genome Resources | ||||
| Parkinson's disease | GIGYF2* | Gigyf2 | Alliance of Genome Resources | ||||
| Parkinson's disease | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
| Parkinson's disease | GBA1* | Gba1 | Alliance of Genome Resources | ||||
| Parkinson's disease | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
| Parkinson's disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| Parkinson's disease | EPO* | Epo | Alliance of Genome Resources | ||||
| Parkinson's disease | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| Parkinson's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| Parkinson's disease | DNAJC13* | Dnajc13 | Alliance of Genome Resources | ||||
| Parkinson's disease | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
| Parkinson's disease | DDC* | Ddc | Alliance of Genome Resources | ||||
| Parkinson's disease | HSPA8* | Hspa8 | Alliance of Genome Resources | ||||
| Parkinson's disease | DBH* | Dbh | Alliance of Genome Resources | ||||
| Parkinson's disease | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| Parkinson's disease | CREB1* | Creb1 | Alliance of Genome Resources | ||||
| Parkinson's disease | CHRNB3* | Chrnb3 | Alliance of Genome Resources | ||||
| Parkinson's disease | CAST* | Cast | Alliance of Genome Resources | ||||
| Parkinson's disease | CASP9* | Casp9 | Alliance of Genome Resources | ||||
| Parkinson's disease | CASP3* | Casp3 | Alliance of Genome Resources | ||||
| Parkinson's disease | ATP13A2* | Atp13a2 | Alliance of Genome Resources | ||||
| Parkinson's disease | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
| Parkinson's disease | ATM* | Atm | Alliance of Genome Resources | ||||
| Parkinson's disease | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| Parkinson's disease | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| Parkinson's disease | A2M* | A2m | Alliance of Genome Resources | ||||
| Parkinson's disease | HSPA9* | Hspa9 | Alliance of Genome Resources | ||||
| Parkinson's disease | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
| Parkinson's disease | HTT* | Htt | Alliance of Genome Resources | ||||
| Parkinson's disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
| Parkinson's disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
| Parkinson's disease | LRRK2* | Lrrk2 | Alliance of Genome Resources | ||||
| Parkinson's disease | MAOB* | Maob | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPK3* | Mapk3 | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
| Parkinson's disease | MAPT-AS1* | ||||||
| Parkinson's disease | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
| Parkinson's disease | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
| Parkinson's disease | ND3* | mt-Nd3 | Alliance of Genome Resources | ||||
| Parkinson's disease | ND4* | mt-Nd4 | Alliance of Genome Resources | ||||
| Parkinson's disease | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| Parkinson's disease 15 | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
| Parkinson's disease 19A | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
| Parkinson's disease 20 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
| Parkinson's disease 22 | CHCHD2*, CHCHD2P9 | Chchd2, Chchd2-ps | Alliance of Genome Resources | ||||
| Parkinson's disease 23 | VPS13C* | Vps13c | Alliance of Genome Resources | ||||
| Parkinson's disease 25 | PTPA* | Ptpa | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia | PRDM13* | Prdm13 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 11 | TBC1D23* | Tbc1d23 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 12 | COASY* | Coasy | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 13 | VPS51* | Vps51 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 15 | CDC40* | Cdc40 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 16 | MINPP1* | Minpp1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1A | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1B | EXOSC3* | Exosc3 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1C | EXOSC8* | Exosc8 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1D | EXOSC9* | Exosc9 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1E | SLC25A46* | Slc25a46 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 1F | EXOSC1* | Exosc1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2A | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2B | TSEN2* | Tsen2 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2C | TSEN34* | Tsen34 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2D | SEPSECS* | Sepsecs | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2E | VPS53* | Vps53 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 2F | TSEN15* | Tsen15 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 3 | PCLO* | Pclo | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 4 | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 5 | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 6 | RARS2* | Rars2 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 7 | TOE1* | Toe1 | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 8 | CHMP1A* | Chmp1a | Alliance of Genome Resources | ||||
| pontocerebellar hypoplasia type 9 | AMPD2* | Ampd2 | Alliance of Genome Resources | ||||
| primary cerebellar degeneration | SIL1* | Sil1 | Alliance of Genome Resources | ||||
| scapuloperoneal spinal muscular atrophy | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
| spastic ataxia | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
| spastic ataxia | COQ4* | Coq4 | Alliance of Genome Resources | ||||
| spastic ataxia | CHP1* | Chp1 | Alliance of Genome Resources | ||||
| spastic ataxia 1 | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
| spastic ataxia 2 | KIF1C* | Kif1c | Alliance of Genome Resources | ||||
| spastic ataxia 3 | MARS2* | Mars2 | Alliance of Genome Resources | ||||
| spastic ataxia 4 | MTPAP* | Mtpap | Alliance of Genome Resources | ||||
| spastic ataxia 5 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
| spastic ataxia 8 | NKX6-2* | Nkx6-2 | Alliance of Genome Resources | ||||
| spinal muscular atrophy | AR* | Ar | Alliance of Genome Resources | ||||
| spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | ||||
| spinal muscular atrophy | ANKRD1* | Ankrd1 | Alliance of Genome Resources | ||||
| spinal muscular atrophy | VAPB* | Vapb | Alliance of Genome Resources | ||||
| spinal muscular atrophy | HEXB* | Hexb | Alliance of Genome Resources | ||||
| spinal muscular atrophy | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
| spinal muscular atrophy, Jokela type | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 1 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 2A | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 2B | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with lower extremity predominant 2B | ND6* | mt-Nd6 | Alliance of Genome Resources | ||||
| spinal muscular atrophy with progressive myoclonic epilepsy | ASAH1* | Asah1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia 44 | GRM1* | Grm1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia 45 | FAT2* | Fat2 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia 46 | PLD3* | Pld3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 10 | ATXN10* | Atxn10 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 11 | TTBK2* | Ttbk2 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 12 | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 13 | KCNC3* | Kcnc3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 15 | ITPR1* | Itpr1 | 2 models | Alliance of Genome Resources | |||
| spinocerebellar ataxia type 19/22 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 21 | TMEM240* | Tmem240 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 23 | PDYN* | Pdyn | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 25 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 26 | EEF2* | Eef2 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 29 | ITPR1* | Itpr1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 31 | BEAN1* | Bean1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 34 | ELOVL4* | Elovl4 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 35 | TGM6* | Tgm6 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 36 | NOP56* | Nop56 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 37 | DAB1* | Dab1 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 38 | ELOVL5* | Elovl5 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 4 | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 40 | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
| spinocerebellar ataxia type 8 | ATXN8* | ||||||
| spinocerebellar ataxia type 8 | ATXN8OS* | ||||||
| spinocerebellar ataxia with axonal neuropathy 2 | SETX* | Setx | Alliance of Genome Resources | ||||
| spinocerebellar ataxia with axonal neuropathy type 3 | COA7* | Coa7 | Alliance of Genome Resources | ||||
| SPOAN syndrome | KLC2* | Klc2 | Alliance of Genome Resources | ||||
| stress-induced childhood-onset neurodegeneration with variable ataxia and seizures | ADPRS* | Adprs | Alliance of Genome Resources | ||||
| striatonigral degeneration | VAC14* | Vac14 | Alliance of Genome Resources | ||||
| striatonigral degeneration | NUP62* | Nup62 | Alliance of Genome Resources | ||||
| tauopathy | MAPT* | Mapt | Alliance of Genome Resources | ||||
| X-linked spinal muscular atrophy 2 | UBA1* | Uba1 | Alliance of Genome Resources | ||||
| X-linked spinocerebellar ataxia 1 | ATP2B3* | Atp2b3 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| Alzheimer's disease | Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte | 1 model | |
| Alzheimer's disease | Tg(Thy1-MAPT*P301L)2Vln | 1 model | |
| Alzheimer's disease | Tg(Thy1-MAPT)22Schd | 2 models | |
| Alzheimer's disease | Tg(Thy1-MAPT)2Vln | 2 models | |
| Alzheimer's disease | Tg(Thy1-MAPT)1Vln | 2 models | |
| Alzheimer's disease | Tg(Thy1-APPSweLon)41Ema | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSweAut)A7Tiwa | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSweArc)BLngn | 1 model | |
| Alzheimer's disease | Tg(Thy1-APPSwDutIowa)BWevn | 3 models | |
| Alzheimer's disease | Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr | 3 models | |
| Alzheimer's disease | Tg(Thy1-APPSw)10Jiri | 3 models | |
| Alzheimer's disease | Tg(Thy1-APPLon)2Vln | 4 models | |
| Alzheimer's disease | Tg(Thy1-APPArc)M8Cagr | 2 models | |
| Alzheimer's disease | Tg(Thy1-APPSL)28Lpr | 4 models | |
| Alzheimer's disease | Tg(Thy1-APP*Swe*Ind)fAccu | 1 model | |
| Alzheimer's disease | Tg(Thy1-APP*)2Tbay | 1 model | |
| Alzheimer's disease | Tg(Thy1-APP)3Somm | 3 models | |
| Alzheimer's disease | Tg(tetO/Prnp-APP*Swe*Lon)9191Krz | 1 model | |
| Alzheimer's disease | Tg(tetO-MAPT*K280,-luc)#Eman | 1 model | |
| Alzheimer's disease | Tg(tetO-HMOX1)6Hyms | 1 model | |
| Alzheimer's disease | Tg(tetO-CDK5R1/GFP)337Lht | 1 model | |
| Alzheimer's disease | Tg(tetO-APPSwInd)Dbo | 2 models | |
| Alzheimer's disease | Tg(tetO-APPSwInd)107Dbo | 1 model | |
| Alzheimer's disease | Tg(tetO-APPSwInd)102Dbo | 1 model | |
| Alzheimer's disease | Tg(tetO-APPSwInd)18Dbo | 1 model | |
| Alzheimer's disease | Tg(PSEN1H163R)G9Btla | 1 model | |
| Alzheimer's disease | Tg(PSEN1dE9)S9Dbo | 4 models | |
| Alzheimer's disease | Tg(Prnp-MAPT*P301S)PS19Vle | 3 models | |
| Alzheimer's disease | Tg(Prnp-MAPT*P301L)JNPL3Hlmc | 2 models | |
| Alzheimer's disease | Tg(Prnp-MAPT*K274Q*K281Q)286Lgn | 1 model | |
| Alzheimer's disease | Tg(Prnp-MAPT)43Vle | 1 model | |
| Alzheimer's disease | Tg(Prnp-MAPT)7Vle | 1 model | |
| Alzheimer's disease | Tg(Prnp-ITM2B/APP695*42)A12Emcg | 1 model | |
| Alzheimer's disease | Tg(Prnp-ITM2B/APP695*40)1Emcg | 1 model | |
| Alzheimer's disease | Tg(PRNP-APPSweInd)19959Dwst | 1 model | |
| Alzheimer's disease | Tg(PRNP-APPSweInd)8Dwst | 3 models | |
| Alzheimer's disease | Tg(Prnp-APPSweArc)#Rmni | 1 model | |
| Alzheimer's disease | Tg(Prnp-App/APPswe)E1-2Dbo | 1 model | |
| Alzheimer's disease | Tg(Prnp-APP*)1Hmor | 1 model | |
| Alzheimer's disease | Tg(PDGFB-MAPT*V337M)1Atak | 1 model | |
| Alzheimer's disease | Tg(PDGFB-APPSwInd)J9Lms | 1 model | |
| Alzheimer's disease | Tg(PDGFB-APPSwDutLon)46Lpr | 2 models | |
| Alzheimer's disease | Tg(PDGFB-APPInd)F17Plhn | 1 model | |
| Alzheimer's disease | Tg(NEFL-APP)#Nalb | 1 model | |
| Alzheimer's disease | Tg(Mapt-MAPT*)#Hanr | 1 model | |
| Alzheimer's disease | Tg(Eno2-PSEN2*)1480Ykk | 1 model | |
| Alzheimer's disease | Tg(Eno2-PSEN2)2348Ykk | 1 model | |
| Alzheimer's disease | Tg(Eno2-APP*Ind)#Kakiz | 1 model | |
| Alzheimer's disease | Tg(DMD-APP*)18Neve | 1 model | |
| Alzheimer's disease | Tg(DMD-APP*)7Neve | 1 model | |
| Alzheimer's disease | Tg(CMV-IgkvaD11)BCat | 2 models | |
| Alzheimer's disease | Tg(Camk2a-App*,-Apbb1)25Spim | 1 model | |
| Alzheimer's disease | Tg(APPV717F)109Ili | 9 models | |
| Alzheimer's disease | Tg(APPSwLon)96Btla | 1 model | |
| Alzheimer's disease | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 8 models | |
| Alzheimer's disease | Tg(APPswe,PSEN1dE9)85Dbo | 6 models | |
| Alzheimer's disease | Tg(APPSWE)2576Kha | 13 models | |
| Alzheimer's disease | Tg(APPSw)40Btla | 2 models | |
| Alzheimer's disease | Tg(APP)8.9Btla | 1 model | |
| Alzheimer's disease | Tg(APP695)3Dbo | 8 models | |
| Alzheimer's disease | Tg(ACTB-APP*V717F)1Colm | 1 model | |
| Alzheimer's disease 3 | Tg(PSEN1H163R)G9Btla | 1 model | |
| Alzheimer's disease 3 | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 1 model | |
| Alzheimer's disease 3 | Tg(PSEN1dE9)S9Dbo | 4 models | |
| Alzheimer's disease 3 | Tg(APPswe,PSEN1dE9)85Dbo | 2 models | |
| Alzheimer's disease 4 | Tg(APP695)3Dbo | 3 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)#Roos | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(Myl1-SOD1*G93A)#Amu | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(NEFH)200Jpj | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(NFH)120Jpj | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(Prnp-Immt/SOD1*G93A)7Gmnf | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Prnp-SOD1*G37R,-PSEN1)110Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*)125Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*)D-14Dbo | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*)DF7Yaw | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)1Dwc | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)9Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)29Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)42Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)106Dpr | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)74Dwc | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)148Dwc | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)641Alho | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)737Alho | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Sod1*G86R)M1Jwg | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)1Gur | 6 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)2Gur | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)dl1Gur | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*G127X)716Mrkl | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)#Maw | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)IAra | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)LAra | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)58Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)139Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)45Dbo | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)#Deng | 2 models | |
| amyotrophic lateral sclerosis type 1 | Tg(Thy1-DCTN1*G59S)M2Pcw | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Thy1-Sncg)HvP36Putt | 1 model | |
| amyotrophic lateral sclerosis type 1 | Tg(Thy1-SOD1*G93A)T3Hgrd | 2 models | |
| amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP*A315T)13Lmit | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP)4Jlel | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*A315T)23Jlel | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*A315T)95Balo | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*Q331K)103Dwc | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(TARDBP)#Jpj | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(TARDBP*A315T)#Jpj | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(TARDBP*G348C)#Jpj | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP)12Vle | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP*)BOddo | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP)6Singh | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP)4Singh | 2 models | |
| amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP*)4Vle | 2 models | |
| amyotrophic lateral sclerosis type 10 | Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu | 1 model | |
| amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
| amyotrophic lateral sclerosis type 15 | Tg(Thy1-UBQLN2*P506T)6Mont | 1 model | |
| amyotrophic lateral sclerosis type 15 | Tg(Thy1-UBQLN2*P497S)3Mont | 1 model | |
| amyotrophic lateral sclerosis type 4 | Tg(Prnp-SETX*R2136H)1920Als | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Prnp-FUS*R521C)3313Ejh | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Thy1-FUS*)19Vlb | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Thy1-FUS*)1Dit | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(Prnp-FUS)WT3Cshw | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(CAG-lacZ,-FUS,-EGFP)629Gyu | 1 model | |
| amyotrophic lateral sclerosis type 6 | Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu | 1 model | |
| amyotrophic lateral sclerosis type 8 | Tg(Thy1-VAPB*P56S,-EGFP)D3Cai | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)150Dbo | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(ATN1*)Q129Stsu | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)3Tx | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)14Tx | 1 model | |
| dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)124Dbo | 1 model | |
| familial encephalopathy with neuroserpin inclusion bodies | Tg(Thy1-SERPINI1*G392E)333Icka | 2 models | |
| fragile X-associated tremor/ataxia syndrome | Tg(Pcp2-FMR1*)1Dln | 1 model | |
| fragile X-associated tremor/ataxia syndrome | Tg(tetO-FMR1*,-EGFP)#Rkhu | 2 models | |
| frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | Tg(C9orf72)500Lpwr | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q)61Gschi | 1 model | |
| Huntington's disease | Tg(YAC128)#Hay | 1 model | |
| Huntington's disease | Tg(YAC128)55Hay | 2 models | |
| Huntington's disease | Tg(YAC128)53Hay | 1 model | |
| Huntington's disease | Tg(YAC72)2511Hay | 2 models | |
| Huntington's disease | Tg(UBC-GFP/HTT*84Q)22Shya | 1 model | |
| Huntington's disease | Tg(tetO-HTT*94Q,-lacZ)1Rhn | 1 model | |
| Huntington's disease | Tg(Prnp-SNAP25/HTT*150Q)8Xjl | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q,KRT14-EGFP)C63Dbo | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q)52Caro | 1 model | |
| Huntington's disease | Tg(Prnp-HTT*82Q)8AGschi | 1 model | |
| Huntington's disease | Tg(Ppp1r1b-HTT*)1Meeh | 1 model | |
| Huntington's disease | Tg(Plp1-HTT*150Q)4aXjl | 1 model | |
| Huntington's disease | Tg(HTT*/EGFP)190Nn | 1 model | |
| Huntington's disease | Tg(HTT*/EGFP)150Nn | 1 model | |
| Huntington's disease | Tg(HTT*)NXwy | 1 model | |
| Huntington's disease | Tg(HTT*)LXwy | 1 model | |
| Huntington's disease | Tg(HTT*)1Xwy | 1 model | |
| Huntington's disease | Tg(HTT*97Q)IXwy | 2 models | |
| Huntington's disease | Tg(HDexon1)62Gpb | 3 models | |
| Huntington's disease | Tg(HDexon1)61Gpb | 1 model | |
| Huntington's disease | Tg(HD)63Aron | 1 model | |
| Huntington's disease | Tg(HD82Gln)81Gschi | 3 models | |
| Huntington's disease | Tg(GFAP-HTT*160Q)31Xjl | 1 model | |
| Huntington's disease | Tg(GFAP-HTT*160Q)1Xjl | 1 model | |
| Huntington's disease | Tg(CMV-HTT*89Q)ATag | 2 models | |
| Huntington's disease | Tg(CMV-HTT*48Q)BTag | 2 models | |
| Huntington's disease | Tg(CAG-Ppard*E411P)#Als | 1 model | |
| Huntington's disease-like 2 | Tg(JPH3-GFP,-JPH3*)GXwy | 1 model | |
| Huntington's disease-like 2 | Tg(JPH3*)CXwy | 1 model | |
| Kennedy's disease | Tg(AR*100Q)#Als | 1 model | |
| Kennedy's disease | Tg(AR*100Q)C25Als | 1 model | |
| Kennedy's disease | Tg(AR*100Q)C32Als | 1 model | |
| Kennedy's disease | Tg(ACTA1-Ar)141Kyjo | 1 model | |
| Kennedy's disease | Tg(Prnp-AR*112Q)#Deme | 1 model | |
| Kennedy's disease | Tg(CAG-AR*97Q)7-8Sobue | 1 model | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*70Q)70.61Olri | 1 model | |
| Machado-Joseph disease | Tg(CMV-ATXN3*94Q)94Pama | 2 models | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)NLS.28Olri | 1 model | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)148.19Olri | 1 model | |
| Machado-Joseph disease | Tg(ATXN3*)67.2Cce | 2 models | |
| Machado-Joseph disease | Tg(ATXN3*)84.2Cce | 3 models | |
| Machado-Joseph disease | Tg(Prnp-ATXN3*79Q)#Hlw | 1 model | |
| Machado-Joseph disease | Tg(Htt-ATXN3*148Q)3746Thsc | 1 model | |
| Machado-Joseph disease | Tg(Pcp2-ATXN3*69Q)bHirai | 1 model | |
| Machado-Joseph disease | Tg(CMV-ATXN3*135Q)CPama | 1 model | |
| motor neuron disease | Tg(Thy1-BSCL2*N88S)1Dit | 1 model | |
| multiple system atrophy | Tg(Cnp-SNCA)M2Vle | 1 model | |
| multiple system atrophy | Tg(Mbp-SNCA)1Ema | 1 model | |
| multiple system atrophy | Tg(Plp1-SNCA)1Haa | 1 model | |
| multiple system atrophy | Tg(Mbp-SNCA)29Ema | 1 model | |
| neurodegeneration with brain iron accumulation 3 | Tg(PGK1-FTL*)#Sle | 1 model | |
| neurodegeneration with brain iron accumulation 3 | Tg(Prnp-FTL*)4Ruvi | 1 model | |
| Parkinson's disease | Tg(CAG-SNCA*)1.1Ccs | 1 model | |
| Parkinson's disease | Tg(DBH-SNCA)#Dwei | 1 model | |
| Parkinson's disease | Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan | 1 model | |
| Parkinson's disease | Tg(PDGF-S100B)36Cqin | 1 model | |
| Parkinson's disease | Tg(Snca-SNCA/GFP)#Jyl | 1 model | |
| Parkinson's disease | Tg(tetO-HMOX1)6Hyms | 1 model | |
| Parkinson's disease | Tg(tetO-SNCA)0Olri | 1 model | |
| Parkinson's disease | Tg(Th-SNCA)5Eric | 2 models | |
| Parkinson's disease | Tg(Th-SNCA*)1.2Ccs | 1 model | |
| Parkinson's disease | Tg(Th-SNCA*A30P*A53T)39Eric | 1 model | |
| Parkinson's disease | Tg(Th-Twnk*,-EGFP)2Gcor | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA*E57K)16Ema | 1 model | |
| Parkinson's disease 1 | Tg(THY1-SNCA*A53T)M53Sud | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA*A30P)18Pjk | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA*)#Ztzh | 1 model | |
| Parkinson's disease 1 | Tg(Thy1-SNCA)61Ema | 1 model | |
| Parkinson's disease 1 | Tg(Th-SNCA*)1702Yosh | 1 model | |
| Parkinson's disease 1 | Tg(Snca-SNCA)#Galt | 1 model | |
| Parkinson's disease 1 | Tg(SNCA*E46K)3Elan | 1 model | |
| Parkinson's disease 1 | Tg(SNCA)ARyot | 1 model | |
| Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)AAub | 2 models | |
| Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)83Vle | 2 models | |
| Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)25Mkle | 1 model | |
| Parkinson's disease 1 | Tg(PDGFB-SNCA/EGFP)78Ema | 1 model | |
| Parkinson's disease 1 | Tg(PDGFB-SNCA*A53T)8Ema | 1 model | |
| Parkinson's disease 1 | Tg(PDGFB-SNCA)4Ema | 1 model | |
| Parkinson's disease 2 | Tg(Slc6a3-PARK2*Q311X)AXwy | 1 model | |
| Parkinson's disease 4 | Tg(Thy1-Snca)1S13Putt | 1 model | |
| Parkinson's disease 8 | Tg(PDGFB-LRRK2*R1441C)31Hlw | 1 model | |
| Parkinson's disease 8 | Tg(PDGFB-LRRK2*G2019S)32Hlw | 1 model | |
| Parkinson's disease 8 | Tg(Lrrk2*G2019S)2Yue | 1 model | |
| spinocerebellar ataxia type 1 | Tg(tetO-ATXN1*82Q)#Horr | 1 model | |
| spinocerebellar ataxia type 1 | Tg(Pcp2-ATXN1*82Q)5Horr | 1 model | |
| spinocerebellar ataxia type 10 | Tg(Prnp-lacZ/ATXN10*)#Teas | 1 model | |
| spinocerebellar ataxia type 14 | Tg(tetO-PRKCG*S361G,-GFP)3Jpka | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)105Xjl | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-27Xjl | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-16Xjl | 1 model | |
| spinocerebellar ataxia type 17 | Tg(Pcp2-TBP*)69Hmhl | 1 model | |
| spinocerebellar ataxia type 2 | Tg(ATXN2*72Q)#Plt | 1 model | |
| spinocerebellar ataxia type 2 | Tg(Pcp2-ATXN2*127Q)#Plt | 1 model | |
| spinocerebellar ataxia type 5 | Tg(tetO-SPTBN2*)#Lpwr | 1 model | |
| spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)6076Als | 1 model | |
| spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)1963Als | 1 model | |
| spinocerebellar ataxia type 7 | Tg(Pcp2-SCA7)P7EJman | 1 model | |
| spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2542Als | 1 model | |
| spinocerebellar ataxia type 7 | Tg(RHO-SCA7)R7EJman | 1 model | |
| spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2521Als | 1 model | |
| tauopathy | Tg(Mapt-MAPT*)#Hanr | 1 model | |
| tauopathy | Tg(Prnp-MAPT*)2652Gds | 1 model | |
| tauopathy | Tg(Prnp-MAPT*P301S)50Hiw | 1 model | |